Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Siegelin, Markus D  [Clear All Filters]
2014
Pareja F, Macleod D, Shu C, Crary JF, Canoll PD, Ross AH, Siegelin MD. PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Down-regulation of Mcl-1 and phospho-BAD. Mol Cancer Res. 2014.
2015
Schneider M, Ströbele S, Nonnenmacher L, Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S, Strauss G, Baumann B, et al. A paired comparison between glioblastoma 'stem cells' and differentiated cells. Int J Cancer. 2015.
Ströbele S, Schneider M, Schneele L, Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massle G, Westhoff M-A, Halatsch M-E, Debatin K-M. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy. PLoS One. 2015;10(6):e0131670.
Karpel-Massler G, Bâ M, Shu C, Halatsch M-E, Westhoff M-A, Bruce JN, Canoll P, Siegelin MD. TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo. Oncotarget. 2015.
2016
Karpel-Massler G, Banu MA, Shu C, Halatsch M-E, Westhoff M-A, Bruce JN, Canoll P, Siegelin MD. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo. Oncotarget. 2016.
2024
Schneider M, Potthoff A-L, Karpel-Massler G, Schuss P, Siegelin MD, Debatin K-M, Duffau H, Vatter H, Herrlinger U, Westhoff M-A. The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours. Mol Oncol. 2024.
Al-Dalahmah O, Lam M, McInvale JJ, Qu W, Nguyen T, Mun J-Y, Kwon S, Ifediora N, Mahajan A, Humala N, et al. Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons. Cell Stem Cell. 2024.